CD4 and infection: Thus, we can assume that in settings (like Cotonou) where, during the study period, ART was initiated in patients with advanced infection (CD4<200/mm3 or WHO clinical stage 3 with CD4<350/mm3 or WHO stage 4 regardless of CD4 cell count) [33], older people were more likely to be treated.